Cengiz Başar

483 total citations
22 papers, 375 citations indexed

About

Cengiz Başar is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Cengiz Başar has authored 22 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 5 papers in Surgery and 4 papers in Epidemiology. Recurrent topics in Cengiz Başar's work include Cardiovascular Disease and Adiposity (4 papers), Blood Pressure and Hypertension Studies (4 papers) and Cardiovascular Function and Risk Factors (3 papers). Cengiz Başar is often cited by papers focused on Cardiovascular Disease and Adiposity (4 papers), Blood Pressure and Hypertension Studies (4 papers) and Cardiovascular Function and Risk Factors (3 papers). Cengiz Başar collaborates with scholars based in Türkiye, United Kingdom and Poland. Cengiz Başar's co-authors include Hakan Özhan, Mesut Aydın, İsmail Erden, Recai Alemdar, Serkan Ordu, Mehmet Yazıcı, Âdem Güngör, Yasin Türker, Feyzullah Beşli and Ramazan Memişoğulları and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medicine and Journal of Infection.

In The Last Decade

Cengiz Başar

21 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cengiz Başar Türkiye 11 169 122 75 69 45 22 375
Sri W. Aitken United Kingdom 6 180 1.1× 44 0.4× 44 0.6× 19 0.3× 50 1.1× 6 370
Shu Qin China 12 287 1.7× 63 0.5× 8 0.1× 84 1.2× 46 1.0× 31 586
Ehsan Amini‐Salehi Iran 12 59 0.3× 172 1.4× 17 0.2× 60 0.9× 59 1.3× 64 423
D L Miller United States 10 20 0.1× 113 0.9× 51 0.7× 132 1.9× 102 2.3× 20 373
Jonathan P. Law United Kingdom 11 126 0.7× 41 0.3× 112 1.5× 9 0.1× 58 1.3× 19 329
Martial Moonen Belgium 8 55 0.3× 20 0.2× 164 2.2× 18 0.3× 44 1.0× 20 348
Fatma Sema Oymak Türkiye 10 43 0.3× 99 0.8× 19 0.3× 54 0.8× 57 1.3× 34 388
A.D. Pinna Italy 10 56 0.3× 71 0.6× 79 1.1× 72 1.0× 243 5.4× 25 604
PE Ballmer Switzerland 6 48 0.3× 33 0.3× 30 0.4× 29 0.4× 98 2.2× 25 279
Alev Bakır Türkiye 10 26 0.2× 148 1.2× 35 0.5× 22 0.3× 49 1.1× 34 307

Countries citing papers authored by Cengiz Başar

Since Specialization
Citations

This map shows the geographic impact of Cengiz Başar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cengiz Başar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cengiz Başar more than expected).

Fields of papers citing papers by Cengiz Başar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cengiz Başar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cengiz Başar. The network helps show where Cengiz Başar may publish in the future.

Co-authorship network of co-authors of Cengiz Başar

This figure shows the co-authorship network connecting the top 25 collaborators of Cengiz Başar. A scholar is included among the top collaborators of Cengiz Başar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cengiz Başar. Cengiz Başar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Başar, Cengiz, et al.. (2016). Assessment of myocardial performance index in hypertensive patients with or without hyperuricaemia. Kardiologia Polska. 74(11). 1339–1345. 2 indexed citations
2.
Beşli, Feyzullah, et al.. (2015). Improvement of the myocardial performance index in atrial fibrilation patients treated with amiodarone after cardioversion. Journal of Interventional Cardiac Electrophysiology. 42(2). 107–115. 5 indexed citations
3.
Beşli, Feyzullah, et al.. (2015). Relationship Between Tei Index and PEP-Derived Myocardial Performance Index in Sinus Rhythm. Medicine. 94(29). e1112–e1112. 5 indexed citations
4.
Başar, Cengiz. (2015). Evaluation of transfer parameters in patients admitted to our hospital with ST-elevation myocardial infarction. Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology. 44(1). 30–6. 1 indexed citations
5.
Türker, Yasin, et al.. (2015). Comparison of Changes in Anxiety and Depression Level Between Dabigatran and Warfarin Use in Patients With Atrial Fibrillation. Clinical and Applied Thrombosis/Hemostasis. 23(2). 164–167. 18 indexed citations
6.
Güngören, Fatih, et al.. (2015). Statin Therapy May not Effect NLR and MPV Levels in Patients With Hypercholesterolemia. Angiology. 67(6). 536–540. 20 indexed citations
7.
Başar, Cengiz, et al.. (2015). The effect of audio-visual education prior to coronary angiography on the state anxiety. 1(8). 5 indexed citations
8.
Başar, Cengiz, et al.. (2014). Myocardial performance index in patients with dipper and nondipper hypertension. Blood Pressure Monitoring. 19(4). 216–219. 5 indexed citations
9.
Başar, Cengiz, et al.. (2014). Serum visfatin and omentin levels in slow coronary flow. Revista Portuguesa de Cardiologia. 33(12). 789–794. 14 indexed citations
10.
Başar, Cengiz, et al.. (2014). Serum visfatin and omentin levels in slow coronary flow. SHILAP Revista de lepidopterología. 33(12). 789–794. 1 indexed citations
11.
Yaykaşlı, Kürşat Oğuz, Hakan Özhan, Ramazan Memişoğulları, et al.. (2013). Association of omentin Val109Asp polymorphism with coronary artery disease. Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology. 14(6). 511–514. 28 indexed citations
12.
Aliağaoğlu, Cihangir, et al.. (2012). Relation of Nickel Allergy with in-Stent Restenosis in Patients Treated with Cobalt Chromium Stents. Annals of Dermatology. 24(4). 426–426. 18 indexed citations
13.
Bulur, Serkan, Hakan Özhan, İsmail Erden, et al.. (2010). Efficacy of olmesartan therapy on fibrinolytic capacity in patients with hypertension. Blood Coagulation & Fibrinolysis. 22(1). 29–33. 4 indexed citations
14.
Erden, İsmail, et al.. (2010). Poor-quality sleep score is an independent predictor of nondipping hypertension. Blood Pressure Monitoring. 15(4). 184–187. 29 indexed citations
15.
Erden, İsmail, et al.. (2010). Echocardiographic manifestations of pandemic 2009 (H1N1) influenza a virus infection. Journal of Infection. 61(1). 60–65. 22 indexed citations
16.
Erden, İsmail, et al.. (2010). The Levels of Asymmetric Dimethylarginine in Patients with Isolated Coronary Artery Ectasia. Electronic Journal of General Medicine. 7(4). 404–409. 1 indexed citations
17.
Özhan, Hakan, İsmail Erden, Serkan Ordu, et al.. (2010). Efficacy of Short-Term High-Dose Atorvastatin for Prevention of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography. Angiology. 61(7). 711–714. 79 indexed citations
18.
Ordu, Serkan, Hakan Özhan, Recai Alemdar, et al.. (2010). Pioglitazone improves ventricular diastolic function in patients with diabetes mellitus: a tissue Doppler study.. PubMed. 65(4). 401–6. 12 indexed citations
19.
Ordu, Serkan, Hakan Özhan, Recai Alemdar, et al.. (2009). Mean platelet volume in patients with dipper and non-dipper hypertension. Blood Pressure. 19(1). 26–30. 23 indexed citations
20.
Özhan, Hakan, et al.. (2009). Mean platelet volume in patients with non-alcoholic fatty liver disease. Platelets. 21(1). 29–32. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026